Healthcare innovation improves treatment, diagnosis, prevention, and disease research. Such innovation is the development of antipsychotics to treat and prevent mental disorders. The first generation of antipsychotics was developed in 1933 in France. Antipsychotics are medications used to treat mental health problems with psychosis symptoms.
Psychotic conditions alter the brain chemistry and inflict life-changing symptoms such as hallucinations, delusions, and disordered thinking. However, first-generation antipsychotics displayed multiple side effects, such as headaches, confusion, and anticholinergic. The second generation was invented in the 1980s with lower dopamine affinity to lower the risks of the side effects in the first generation.
Antipsychotics, formerly known as tranquilizers and neuroleptics, treat people with mental disorders such as schizophrenia, depression, Alzheimer’s disease, and bipolar disorder. Moreover, antipsychotics relieve many people from acute psychosis symptoms and prevent them from relapsing.